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1. Introduction 
In recent years, technological revolutions in genomics and proteomics have revolutionized 
the work of researchers in molecular biology. Through various techniques of data 
generation, they have at their hand in the web a very large amount of information contained 
in public and heterogeneous data sources. Each source has content organized around a 
particular data type like sequences in Uniprot (for proteins) and Genbank (for gene and 
mRNA), protein structure in PDB (Protein Data Bank) and publications in biomedical 
Medline. Their content is heterogeneous in the sense that a similar data can be represented 
differently in two data sources (eg different names for the same gene). More data sources 
have a variety in terms of structure, and there are sources of structured data, such as 
relational databases or semi-structured sources like XML and unstructured sources such as 
databases composed of flat files. That is to say that a biologist who wishes to obtain 
information from these sources have to question these one by one, then copy and analyze 
the data collected, and manage redundancy, complementarities of the information and 
inconsistencies. Today, one of the greatest challenges of bioinformatics is to enable biologists 
to effectively access multiple data sources, each with a different pattern. Various approaches 
have been adopted to unify access to various data sources given a query. Several systems 
have been produced from data warehouses, a federation of databases or mediators. 
In this work, we are interested in mediation systems. Such systems offer to the user a 
uniform and centralized view of distributed data, this view may also reflect a more abstract, 
condensed, qualitative data and therefore more meaningful to the user. These mediation 
systems are also very useful in the presence of heterogeneous data, because they seem to use 
a homogeneous system. 
We aim to assist biologists in their research through the development of a generic tool for 
the integration of heterogeneous genomic data distributed over the web, and we are placed 
in a very particular context that is the study of cardiovascular disease and especially familial 
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hypercholesterolemia. This is a disorder of high LDL ("bad") cholesterol that is passed down 
through families, which means it is inherited. This disease is caused by a genetic mutation of 
certain lipoproteins. Indeed, these lipoproteins (called LDL) carry the 2/3 of cholesterol 
circulating in the blood; they deliver cholesterol to tissues by a system of recognition 
between Apo lipoprotein Band a receiver: the LDL receptor (lock and key system) that 
allows the entry of LDL and their cholesterol content in cells. When the LDL receptor (LDL-
R) is weak (about one mutation), LDL accumulates in the blood and artery walls causing 
familial hypercholesterolemia (HF). So knowing these different mutations by biologists, can 
greatly facilitate the molecular screening of the disease and therefore to find the proper 
treatment. However, to answer such a query: “What are the mutations that cause familial 
hypercholesterolemia (HF)?” The biologist hasto make a fastidious search in disparate and 
heterogeneous databases which requires a considerable investment time.  
This chapter is structured as following: 
 First we present the background of the project 
 Second we focus on the problem of heterogeneity of data sources and biological 
characteristics of these sources. 
 Third we present the state of the art of data integration, problems and constraints of this 
integration and the various existing approaches to solve this problem. 
 And fourth we expose studied scenario, the realization and perspectives. 
2. General context 
Since the completion of the human genome sequencing in April 2003, we observe the 
accumulation of an outsize amounts of genomic and proteomic data on the web often 
syntactically and semantically heterogeneous and difficult to capitalize.  
Information about genes provides access to their corresponding proteins. In addition, all 
diseases are associated with alterations in the structure or function of such proteins. A good 
knowledge of protein structure provides insight into their function.  
Bioinformatics has become an important tool to explore genomic data by relying heavily on 
computer systems. It suggests methods and software’s for biological data storage and 
processing. Actually, it is acquiring and organizing data, developing software for the 
analysis, comparison and modeling of these data and analysis results produced by 
bioinformatics software to infer new biological knowledge, in collaboration with biologists. 
This work contributes to facilitate to biologists searching among heterogeneous and 
distributed data in public and / or private data sources on the web. In particular, it helps 
them to analyze proteins, by building a platform for integrating biological data. This will 
provide a tracking system to target special proteins involved in a disease known as familial 
hypercholesterolemia and thus, to better understand the biological activity of these 
macromolecules.  
Familial hypercholesterolemia disease results from mutations in the LDLR gene. The LDLR 
gene provides instructions for making a protein called a low-density lipoprotein receptor. 
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This type of receptor binds to particles called low-density lipoproteins (LDLs), commonly 
known as bad cholesterol. By removing low-density lipoproteins from the bloodstream, 
these receptors play a critical role in regulating cholesterol levels. When the LDL receptor 
(LDL-R) is deficient, LDL accumulated in arteries induces the familial hypercholesterolemia 
(HF) pathology. So, in biology knowing these different mutations can greatly facilitate the 
molecular screening of the disease and thus find appropriate treatment.  
3. Biological data sources 
Number of data sources and tools available to biologists on the web has grown dramatically 
in recent years. This huge number of available data along with heterogeneous information 
generated wide variety of access interfaces, and also a profound heterogeneity. 
3.1. Genomic databases 
There are two types of databanks, those that correspond to a set of heterogeneous data so-
called "databases" and those more homogeneous established around a specific theme. 
Also, to avoid confusion we will distinguish between semantic databases, general [2] and 
specialized [3]databases. 
For specific requirements related to the activity of a group, or to bibliographic compilations, 
many specific databases were created in laboratories. In some cases, these databases have 
been developed continuously; others have not been updated and disappeared as they 
represented a specific need. Still others are unknown or poorly known and are waiting for 
further investigation. 
All these specialized databases of interest may vary considerably from one base to another 
according to their size. In most of the case, these bases correspond to a combination 
compared of generalist databases such as: Swiss-Prot, GenBank. DDBJ (DNA Data Bank of 
Japan), EMBL (European Molecular Biology Laboratory) which are used very often. It is 
important to know, that according to the field of activity or the genomics research, the 
surveyed banks are not necessarily the same. The genomic libraries contain various 
information that may include: 
 Characteristics of proteins or genes such as localization of the gene in the cell: 
LocusLink5, the 3D structure of protein: Protein Data Bank (GDP) and Molecular 
Modeling Database (MMDB) or its biological function. More specifically, some 
databases contain information about a specific family of protein such as “Enzyme8” 
which include exclusively enzyme type proteins.  
 Some phenotypes (specific genes, morphological feature, clinical syndrome ...) or more 
specifically some genetic diseases: Online Mendelian Inheritance in Man (OMIM); 
 Specific species or families of species: FlyBase, Reptilia, Saccharomyces Genome 
Database (SGD), Mouse Genome Database (MGD); 
 The medical literature (banks abstracts): Medline, PubMed. 
 
Lipoproteins – Role in Health and Diseases 152 
Table1 and Table 2 give two examples of genomic databases along with protein database. 
  
Designation Location Roles Comments Web sites and references 
Nucleic bases 
EMBL 
 
 
 
 
 
 
 
 
 
 
 
European 
Bioinform
atics 
Institute 
(EBI) 
Europe 
More than 1 million 
records (January 1998)  
for more than 15,500 
species. 
The predominant species: 
Homo 
sapien,Caenorhabditis 
elegans, 
Saccharomyces 
cerevvisae ... 
Information’
s search 
tools: SRS, 
System 
Retrieval 
System and 
via a web 
interface on 
EBI, through 
BLAST et 
FASTA 
software 
Accessible via the web site: 
http://www.ebi.ac.uk/ebi_docs/em
bl_db/ebi/topembl.html 
Specific genomic resources 
SGD 
Saccharom
yces 
Genome 
Database 
Works of 
Cherry 
and al, 
1998. 
Online resources on 
molecular biology  and  
S.cerevisiae genetic 
Numerous 
research help 
functions  on 
line 
Accessible via the web site: 
http://genome-
www.stanford.edu/Saccharomyce
s/ 
Table 1. Genomic databases 
Designation   Location Roles Comments Web sites and  references 
Primary databases 
PIR 
Protein 
Information 
Resource 
National 
Biomedical 
Research 
Foundation 
Sequences collecting 
to detect  
evolutionary 
relationship between 
proteins  
The current 
structure includes 4 
compartments : 
PIR1,  PIR2, PIR3 
and  PIR4 
Accessible via the web site 
http://nbrfa.georgetown.ed
u/pir/ 
Composite databases 
NRDB 
Non-
redundant 
Database 
National 
Center 
Biotechnology 
Information 
USA 
Composed of 
GenPept (derived 
from GenBank), PDB 
sequences, SWISS-
PROT, SPupdate, 
PIR, and 
GenPeptupdate 
(update of  
GenPept).  
NRDB is the default 
database of  BLAST  
and  NCBI service 
Accessible via the 
web site: 
http://www.ncbi.nl
m.nih.gov/Web/NR
DB/ 
NRDB 
Non-redundant Database 
Table 2. Protein databases 
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3.2. Characteristics of biological data sources 
The diversity of information distributed sources and their heterogeneity are the one of the 
main problem that the web users have to face. This heterogeneity may result from the size or 
structure of the sources (structured sources: relational databases, partially structured 
sources: XML documents, or unstructured: texts), the access mode and query, or semantic 
heterogeneity: between concept maps, and implicit or explicit underlying ontology’s. 
Biological sources have a large heterogeneity at different levels: 
 Syntactic: because of the different formats for describing the content sources usually 
ASN.1 (formal notation for describing data transmitted via exchange protocols), (eg 
Enter), but also more standard formats such as XML (eg GenBank).  
 Semantic which covers several aspects. First, it concerns the focus. However, each base 
focuses on a type of biological object (eg, the focus of Swiss-Prot is the protein, the focus 
of GenBank is gene, and the PDB is the 3D protein structure). 
 Then, according to the base, the same information is not represented with the same level 
of detail: some bases are generalists (eg Swiss-Prot in general on proteins) while others are 
more specialized (eg SGD (Saccharomyces Genome Database) on yeast proteins). 
 The final aspect of semantic heterogeneity is related to the diversity of nomenclature 
modes. Different vocabularies are used to annotate the sequences and the reliance on 
such annotations is seldom complete.  Moreover, within a same database, there are a 
several names for each single entity (protein, gene). The name of an entity may depend 
on the disease to which it is linked or to its inventor.  
 Source query language: another form of heterogeneity comes from query languages. 
Languages are often simple forms (combinations of words to search in a text), in the 
case of portals or simple databases. But one can also find structured languages such as 
SQL or OQL. 
 Protocols for collecting data that are different such as CGI / HTTP or FTP. Access to 
web sources is limited to the entry forms and their underlying programs 
 The tools offered by the Web: there are many tools for text searching and sequence 
comparison algorithms such as BLAST (Basic Local Alignment Search Tool), FASTA15 
or LASSAP16. 
4. State of the art of approaches to integration 
A data integration system remedies to the problems associated with the expansion of public 
data sources by giving the possibility to have a unified view of them. Such a system is the 
interface between user and data sources simplifying requests to perform (a request to query 
all sources covered by the system). The user is not obliged to know where the data are and 
how they are structured. 
4.1. Current integration approaches 
There are two major approaches for integration of information: (1) the data warehouse (DW) 
or materialized approach and (2) virtual approach (mediator based).In DW approach, huge 
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amount of historic data is stored in the DW. In the virtual approach, on the other hand, the 
data is not materialized, but rather is globally manipulated using views. Each of these 
approaches is suitable in some kinds of applications. 
4.1.1. Data warehouse 
DW is a powerful tool for decision support and querying the data because it explicitly stores 
information from heterogeneous sources locally. However, some external data, such as new 
product announcements from opponents and currency exchange rates, may be needed to 
support the accuracy of the business decisions. We should not neglect the importance of 
such data to avoid the problems of incompleteness, inexact, or sometimes wrong results. 
Warehousing huge and frequently changed information is a big challenge for the following 
reasons.  
Firstly, since the data in the DW is loaded in snapshots and the DW is a huge information 
repository. Secondly, as the data sources change frequently, the maintenance becomes a 
complicated and costly issue 
Here are two examples of using data warehouses: 
 Genomics Unified Schema, GUS [4] is a system for creating a data warehouse focused 
on molecular biology; 
 Gene Expression Data Warehouse, GEDAW [5] is a warehouse dedicated to the analysis 
of the transcriptome of human liver. 
 
Figure 1. Simple schematic for a data warehouse 
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4.1.2. The virtual approach (mediator based) 
In this approach, the actual data resides in the sources, and queries against the integrated 
‘virtual’ view will be decomposed into sub queries and posed to the sources. This approach 
is preferred over the materialized approach DW when the information sources change very 
often. On the other hand, the DW approach may be desired when a quick query answer is 
required and the information sources change rarely.   
The most important step in the construction of a mediator is the creation of the global 
schema. The mapping consists on the relations between the global schema and local sources. 
Specification of this mapping, depending on the method, determines the difficulty of query 
reformulation and the facility of adding or removing sources within the system. Two 
methods are commonly used to determine the global schema  
 GAV (Global As View) approach: In this approach, each concept of the global schema is 
mapped to a query over data sources. In other words, when the user presents his/her 
query over the integrated schema, the data corresponds to a concept in the integrated 
schema, which can actually be answered from the data sources through a specific query. 
The query processing in GAV is easy, since it just unfold each concept in the integrated 
schema in the user query with the associated query over the sources, but this approach 
does not help much when the sources change or grow very often, since these factors 
affect the mappings and require restricting the integrated schema. 
 LAV (Local As View) approach: LAV approach defines the mapping in the other way 
around; each concept in the data sources is defined in terms of a query over the 
integrated schema. This makes query processing more difficult, since in this case, the 
system does not know explicitly how to reformulate the concepts in the integrated view 
expressed in the user query in terms of the data sources. On the other hand, changes or 
incremental growth in the sources will not lead to reconstruction of the integrated 
schema, and need only to modify the mappings 
 
Figure 2. GAV vs. LAV 
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Figure 3. Architecture of a mediator 
In fact, these two approaches are not opposite, but complementary; depending on the 
problem to be solved. To integrate a few sources, most of which are stable, better to use the 
GAV method. By cons, as part of a large-scale integration, the LAV method is preferable as a 
material change at a local source with little or no impact on the global schema. 
Two examples of systems integration based mediator: 
 Tambis (Transparent Access To Multiple Bioinformatics Information Sources) [6] is an 
integration system coupled to an ontology that allows for better interoperability 
between sources; 
K2/BioKleisli [7] is a system based on CPL (Collection Programming Language) is a query 
language for high-level querying multiple sources. 
4.1.3. The multi agents approach 
This approach was used in GID-IGC (Integrated Genomic Database - Genome Information 
System) project. The proposed architecture uses a network of agents communicating each 
with other via CORBA and KQML. All have a specific function, such as EIA (External 
Interface Agent) that manages the user interface, or SCA (Dial Selector 
Agent) witch decompose the global query into sub-queries for local data sources. This 
approach is very modular and easily extensible. 
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4.1.4. Navigating between sources 
This approach is based on what users usually do when searching for information on the 
web, which involves a search page to page by clicking the mouse. In practice, queries 
generated for this type of tool are converted into path expressions. The data banks are then 
integrated based on their cross-references. These expressions can answer the query of the 
user according to different levels of satisfaction.  
A reference is a link between two data sources (Figure 4), a bridge between the information 
relating on the same object or the same concept. It can be done through an identifier of an 
external source or a URL (Unified Resource Locator). If the link can be browsed in both 
directions it is a cross-reference ("cross-reference"). 
 
Figure 4. Navigating between sources 
4.2. Adopted approach 
In this work, we are interested in mediation systems. Such systems offer a uniform and 
centralized view of distributed data. This view may also reflect a more abstract, condensed, 
qualitative data and therefore more meaningful to the user. These mediation systems are 
also very useful in the presence of heterogeneous data, because they seem to use a 
homogeneous system. 
In this architecture, each component provides a set of features, which, together will help to 
satisfy the user request at the end. 
 The mediator is a software module that directly receives the user’s request. It has to locate 
the necessary information to answer the query, resolve schematic and semantic conflicts, 
query different sources and integrate the partial results in a consistent and coherent 
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response. This is the most complex component but only one instance of it is necessary 
(unlike multiple adapters). It provides access to multiple data sources as if it was a single 
one and offers this consultation through multiple languages and ontologies. 
 
Figure 5. Adopted approach 
This is a crucial component that allows a local system to distribute its information to a 
community of users. 
 The adapter allows the presentation of data in the mediation’s syntactic format. So it’s 
an interface for querying a database using a standardized language (pivot language). 
 Data source: Represent the sources and banks of biological information. A data source 
can be described by its: 
- Location: Reference, communication protocol, access technique (JDBC, ODBC API), 
support (DBMS, web pages) 
- Type of data it manages: structured (relational, object), semi-structured (XML, 
OEM), unstructured (image, multimedia) 
- Ability to query: SQL, OQL, search 
- Results Format: XML, HTML, relationships, texts 
5. Studied scenario 
After exploring the different integration systems that solve the problem of heterogeneous 
biological data sources, this section describes the scenario we have chosen to work on. 
5.1. Biologist’s need 
The objective of our work is to develop an integration system for biological data with an 
application on familial hypercholesterolemia. Such system should facilitate access to 
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multiple data sources available on the Web, in a transparent and uniform way by giving 
biologists a single virtual source that summarizes the sites of interest to the application. 
In order to satisfy this biologist’s need we studied their current way to work. We first 
focused on existing tools, data sources they use and their functional specifications. 
Tools: they use, mainly: 
 CHARMM (Chemistry at Harvard Macromolecular Mechanics) [8]: This program 
offers a wide choice for the production and analysis of molecular simulations. It 
simulates the standard energy minimization of a given structure and the 
production of a molecular dynamics trajectory. 
 VMD (Visual Molecular Dynamic) [9]: This software is used to visualize the 
molecules available on the web. 
Data sources: The focus was mainly on the following sources: 
 PDB (Protein Data Bank) [10]: It’s a worldwide collection of data on three-
dimensional structure of biological macromolecules: Proteins and nucleic acids. 
The PDB is the primary source of structural biological data. It allows access to 3D 
structures of pharmaceutical interest proteins. 
 PubMed [11]: it’s a free search engine giving access to the MEDLINE bibliographic 
database, gathering citations and abstracts of biomedical research. 
5.2. Adopted scenario 
The adopted scenario consists on building a local database "homemade" that would include 
unorganized data already available in the biologist’s laboratory and for our particular case 
data related to LDL receptor mutations. This goes along with the research we're going to do 
on the Web using the mediation system:  
 
Figure 6. The adopted scenario 
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The integration platform is the mediation system. It will query data sources related to 
cardiovascular diseases especially familial hypercholesterolemia namely: PDB and PubMed. 
The results of the query will be processed by the tool CHARMM before being presented to 
the user [12, 13]. 
5.3. Selected data sources 
PubMed [8]: Is the leading bibliographic data search engine of all fields of biology and 
especially medicine. It was developed by the National Center for Biotechnology Information 
(NCBI), and is hosted by the National Library of Medicine U.S. National Institutes of Health. 
PubMed is a free search engine giving access to the MEDLINE bibliographic database, 
gathering citations and abstracts of biomedical research. 
The MEDLINE database in April 2007 had more than 15 million citations from 1950 
published in 5000 biomedical journals (journals in biology and medicine) distinct. It is the 
database of reference for biomedical sciences. As with other indexes, including a citation in 
PubMed has no content. In addition to MEDLINE, PubMed also provides access to: 
 OldMedline for articles before 1966 
 Citations of all articles, even "irrelevant" (that is to say, covering topics such as plate 
tectonics or astrophysics) from certain MEDLINE journals, primarily those published in 
major newspapers of general science or biochemical (such as Science and Nature, for 
example). 
 Citations being listed before indexing in MEDLINE or MeSH, or passage or status "off 
topic" 
 Older citations selected for MEDLINE journal from which they arise (when they are 
supplied electronically by the publisher) 
 Articles submitted to PubMed Central for free 
Most citations include a link to the full article when it is available (eg PubMed Central). 
PubMed is a search engine that allows users to search in the MEDLINE database; this 
information is also available from private organizations such as Ovid and Silverplatter, 
among others. PubMed is free since the mid-1990s. For optimal use of PubMed, it is 
necessary to have an understanding of his core, MEDLINE, and especially the MeSH 
vocabulary used for indexing articles in MEDLINE. 
We can also find in PubMed information about the log, which can search by title, subject, 
short title, NLM ID, ISO abbreviation, and ISSN (International Standard Serial Number) 
written and electronic. The database "newspaper" includes all newspapers Enter Base. 
The major interest of these bibliographic databases is that: 
 Their bodies are used to identify recent publications in scientific journals. 
 They help to establish bibliographies (lists of relevant articles) on a subject or author. 
 They are portals to access full text documents available on the Internet. 
 The bibliographic databases used to find references to documents, select, print or export 
them to other software. They may also propose to order documents or provide access to 
full text. 
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PDB (Protein Data Bank): The databank on proteins of Research Collaborator for Structural 
Bioinformatics, more commonly known as Protein Data Bank or PDB is a worldwide 
collection of data on the three-dimensional (or 3D structure) of biological macromolecules  : 
protein essentially, and nucleic. 
Founded in 1971 by Brookhaven National Laboratory, the Protein Data Bank was 
transferred in 1998 to the Research Collaborator for Structural Bioinformatics (RCSB), which 
consists of Rutgers University, the University of Wisconsin at Madison, National Institute of 
Standards and Technology (NIST) and the "San Diego Supercomputer Centre." The PDB 
originally contained (in 1971) 7 structures. The number of structures deposited has grown 
since the 1980s. Indeed, at that time, the crystallographic techniques have improved, the 
structures determined by NMR have been added, and the scientific community has changed 
its view on data sharing. 
The PDB containedon 28-04-2008, 50480 structures. The data are from the original pdb 
format, and in recent years are also mmCif format, specifically developed for structural data 
from the PDB. From 2000 to 3000 structures are added each year. The bank contains files for 
each molecular model. These files describe the exact location of each atom of the 
macromolecule studied, that is to say, the Cartesian coordinates of the atom in a three-
dimensional coordinate. 
Each model is referenced in the bank by a unique identifier to 4 characters, the first is always 
a numeric character, the next three being alphanumeric characters. This identifier is called 
"pdb code". 
Several formats exist for PDB files: 
The PDB format: it is the original format. The guide of this format has been revised several 
times; the current version is version 2.2[14], which has existed since 1996. Originally pdb 
format was dictated by the width and the use of punch cards for computers. Consequently, 
each line contains exactly 80 characters. 
Pdb file format is a text file where each column has its meaning: Each parameter is 
positioned so immutable. Thus, the first 6 columns, that is to say the first 6 characters for a 
given line, determine the scope of the file. Found for example in the fields " TITLE_ "(That is 
to say, the title of the macromolecule of interest)," KEYWDS "(The keywords of the entry)," 
EXPDTA "Which provides information on the experimental method used," SEQRES "(The 
sequence of the protein under study),” ATOM_ “Or” HETATM "Fields containing all 
information related to a particular atom. 
Pdb format limitations: Format in 80 columns pdb files is relatively restrictive. The maximum 
number of atoms in a pdb file is 99999, since there are only 5 columns allocated for the 
numbers of atoms. Similarly the number of residues per chain is at most 9999: There are only 4 
columns allowed for this figure. The number of channels is limited to 62: A single column is 
available, and possible values are one of the 26 letters of the alphabet in upper or lower case, or 
one of the digits 0 through 9. As this format has been defined, these limitations did not seem 
restrictive, but they have been taken several times during the deposition of extremely large 
structures, such as viruses, ribosome, and multienzyme complexes. 
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MmCIF format:The growing interest in the development of database and electronic 
publications in the late 1980s has created the need for a more structured, standardized, 
open-ended and high quality data from the PDB. In 1990, the International Union of 
Crystallography IUCr extended to macromolecules data representation used to describe 
crystal structures of molecules of low molecular weight. This representation is called CIF, 
for Crystallographic Information File. The dictionary mmCIF (macromolecular 
Crystallographic Information File) published in 1996, was then developed.  
In MmCIF format, each field of each section of a pdb file is represented by a description of a 
characteristic of an object, which includes both the name of the characteristic (eg 
_struct.entry_id), and the content of the description (pdb code: 1cbn). Which we can call 
"name-value". It is easy to convert, without loss of information, an mmCIF file format pdb, 
since all information is directly analyzed. It is not possible, however, to completely automate 
the conversion of a pdb file format mmCIF, since many mmCIF descriptors are either absent 
from the PDB file, either in this field " REMARK "Who can not always be analyzed. The 
contents of fields " REMARK " is indeed separated according to different mmCIF dictionary 
entries, in order to preserve the completeness of the information contained in such Materials 
and Methods section (crystal characteristics, refinement method ...) or in the description of the 
biologically active molecule or other molecules (substrate, inhibitor, ...) 
The mmCIF dictionary contains over 1700 entries, which are much safer not all used in a 
single PDB file. All field names are preceded by the character "underscore"(_), In order to 
differentiate the values themselves. Each name corresponds to an mmCIF dictionary entry, 
where the characteristics of the object are exactly defined. 
Pdbml format: This format is pdbml adaptation to XML data format bps and contains the 
entries described in the dictionary "PDB Exchange Dictionary". This dictionary contains the 
same entries as the mmCIF dictionary, in order to take into account all data managed and 
distributed by the PDB. This format can store much more information on models than pdb 
format. 
Data retrieval: The files describing molecular models can be downloaded from the website 
of the PDB and visualized using various software such as Rasmol [15], Jmol [16], chime [17] 
or an extension VRML [18] (plugin) a browser. The website of the PDB also contains 
resources for teaching, on structural genomics and other useful software. 
5.4. The global schema 
By studying and exploring the previous sources and by combining data from genome 
sources, we have identified all data that define the dictionary related to familial 
hypercholesterolemia disease (Table 3). From this data dictionary and business rules (as 
defined and established by experts in the field of biology), we extracted the major biological 
entities useful for our study. These entities are not independent and form a semantic graph 
with nodes reflecting relationships between these entities. 
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Property Description
code_biblio Library code
auteur_biblio Author of publication
date_biblio Date of publication
volume_biblio Volume of structure
langue_biblio Language 
contribution_biblio Contribution
journal_biblio Newspaper
revue_scint_biblio Journal
livre_biblio Book
Cd_proceeding_biblio CD procedure
nom_recepteur Name of receiver
nom_mutation Name of mutation
classe_mutation Class of mutation
nom_proteine Name of the protein
longueur_proteine Length of the protein
type_proteine Protein type
structure_summary Summary of the structure
structure_title Under the structure
nom_molecule Name of the molecule
author_name Name of author
date_depot Date Filed
date_release Date of publication
derniere_release Last update
Resolution Resolution
Compound Compound
Classification Classification
molecule_chain_type Channel Type
experimental_methode Experimental method of resolution (RX, NMR) 
 
Table 3. Data Dictionaries 
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Figure 7. Global Schema 
From the global schema, it is possible to make our request and submit it to SQL mediator for 
treatment. For example, the query that givesthe associated protein mutated gene and 
publications on familial hypercholesterolemia is expressed as follows in SQL: 
Select nom_proteine, journal_biblio, auteur_biblio, date_biblio, langue_biblio  
From mRNA, gene g, b bibliography 
Where a.nom_gene = g.nom_gene  
And g.nom_gene in (select nom_gene from recepteurs r, mutation m  
                                   Where r.nom_recepteur = m.nom_recepteur) 
For its execution, the query is first submitted to the mediator which is responsible for 
locating sources and queries them through the wrapper or the associated adapter.It should 
FK_MUTATION_CAUSER_HYPERCHO
FK_MUTATION_CONCERNE_RECEPTEU
FK_ARNM_TRADUIT_PROTEINE
FK_ARNM_TRANSCRIT_GENES
FK_RECEPTEU_EST_GENES
FK_DISPOSE_DISPOSE_PROTEINE
FK_DISPOSE_DISPOSE2_STRUCTUR
FK_DECRITS__DECRITS_D_HYPERCHO
FK_DECRITS__DECRITS_D_BIBLIOGR
Hypercholestérolémie
code_maladie varchar(255) <pk>
Bibliographie
code_biblio
auteur_biblio
date_biblio
volume_biblio
langue_biblio
contribution_biblio
journal_biblio
revue_scient_biblio
livre_biblio
cd_proceeding_biblio
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
<pk>
Récepteurs
nom_recepteur
nom_gene
type_recepteur
varchar(100)
varchar(100)
varchar(100)
<pk>
<fk>
Mutations
nom_mutation
code_maladie
nom_recepteur
classe_mutation
varchar(255)
varchar(255)
varchar(100)
varchar(100)
<pk>
<fk1>
<fk2>
Protéines
nom_proteine
longeur_proteine
type_proteine
sequence_proteine
varchar(100)
varchar(100)
varchar(100)
varchar(100)
<pk>
Gênes
nom_gene
longeur_gene
type_gene
sequence_gene
varchar(100)
varchar(100)
varchar(100)
varchar(255)
<pk>
StructureProtéines
titre_structure
resume_structure
nom_molecule
nom_auteur
date_depot
date_release
derniere_release
experimental_methode
molecule_chaine_type
classification
compound
resolution
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
<pk>
dispose
nom_proteine
titre_structure
varchar(100)
varchar(100)
<pk,fk1>
<pk,fk2>
décrits-dans
code_maladie
code_biblio
varchar(255)
varchar(100)
<pk,fk1>
<pk,fk2>
ARNm
nom_ARNm
nom_proteine
nom_gene
longeur_ARNm
type_ARNm
sequence_ARNm
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
varchar(100)
<pk>
<fk1>
<fk2>
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be noted that the only access point to our sources for interrogation is a web form that, once 
processed through a wrapper, gives us the local sources that we describe below. 
5.5. Analysis of the query 
In the global query, 6 attributes are involved: Nom_proteine, nom_gene, journal_biblio, 
auteur_biblio, date_biblio, langue_biblio shown in the following table along with the 
sources (PubMed (S1), and PDB (S2). 
 
Attributes Lists of sources 
journal_biblio, auteur_biblio, date_biblio,langue_biblio S1 
nom_proteine S2 
nom_gene S2, S1 
Table 4. Identification of sources 
From these sources, we can extract a local schema, for example: 
S1_L (journal_biblio, auteur_biblio, date_biblio, langue_biblio, nom_gene), 
S2_L (nom_proteine, nom_gene) 
From a programming point of view, S1_L and S2_L represent wrapper sources. 
Next section describes the realization in which we develop wrappers, submit queries to the 
mediator, and combine the final result to be presented to the user.  
6. Realization 
We define four steps in the realization: 
 The development of wrapper 
 Definition of "global schema" 
 Correspondence between local tables and global schema 
 Results analysis 
6.1. Step 1: Development of wrappers   
A wrapper is a program that envelops the execution of another program in the way that the 
environment can be more suitable. The mediator requests the various databases via 
wrappers that will extract information from websites of interest. It is necessary to create a 
wrapper for each specific database. 
The sources that we identified in section 4 will be integrated through wrappers. There are 
different types of wrappers depending on the type of pages they incorporate. These can be 
either text files or XML files (Extensible Mark-up Language). It is necessary to know the 
structure of these files and know where the information is located (after any tag, for example). 
Developing wrappers is linked to functional specifications of the sources presented earlier. 
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Wrappers allow therefore the extraction of data to be represented in tables. Indeed, we 
declare the objects and their attributes for each site based on data provided. From all this 
information, local schemas (relational) for each of these databases are established. 
Various programs were written in java. Even if a wrapper has been created for each 
database, they all have the same main structure. To fill out the fields of tables, the wrapper 
accesses the Web site to integrate the page and look for keywords behind which is the value 
to extract. Wrappers are of two types depending on the format of the sources   : Either text 
wrappers or XML wrappers (Figure 8). 
 
Figure 8. Presentation of a wrapper 
Finally, a program that generates and initializes (gives the starting values for all wrappers) 
is created to coordinate everything. This program is also written in Java and integrates all 
the wrappers and their relationships. We thus obtain a set of local tables (Provisional) 
performed by the wrappers. 
6.2. Step 2: Definition of “global schema” 
It is therefore necessary to build the global schema that will be the only interface for user. 
Indeed, the user does not know absolutely how the data are integrated. The global schema is 
a set of relational tables that are defined using local tables (for information). This schema 
was introduced in the previous section. 
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6.3. Step 3: Matches between local tables and global schema 
As the various local tables have been filled by the wrappers and the global schema has been 
established, we should now define the correspondence rules between them in order to 
implement global schema with the extracted information from local schemas. The problem 
is that several sources may correspond to a business table (we must then join conditions on 
these tables) or otherwise a source may have several tables trades. For this, we use the 
Medience server tool. 
Medience Server (Figure 5.2) is a complete environment that treats all matching problems 
(different formats, different representation of business information, dispersal of information 
described in a single business table). It is a "virtual database", because it does not store 
information but analyse the user needs. This tool will serve as a mediator that is to say that 
it will be the unique interface for the user as it will both integrate databases, present data 
and also offers possibility to loop and see only some information tables of interest to the 
user. The use of this tool goes in three steps:  
1. The first step consists on recording data sources and creating associated source tables 
using source files provided by wrappers. The global schema is also implemented by 
local tables. We define the attributes of all tables.  
2. In the second part we define the correspondence rules from source tables to the global 
schema tables. The supply of each table in the global database is defined from the 
records of source tables. It is thus possible to standardize results coming from various 
sources by the definition of a standard type.  
3. The final step is the verification of all components and installation of all matching rules 
to make it operational (Figure 9). 
 
Figure 9. Architecture of Medience 
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Figure 10. Anexample of Medience interface [19] 
6.4. Step 4: Data analysis 
It is therefore possible through a platform like Medience to integrate data sources (BD, Excel 
files, and text files) and view the results in a tabular form. Now, we can process to the 
analysis of the results. For this, the definition of demand in terms of mining must be 
decided: How can we use the data provided. Medience offers the possibility to ask tables on 
the global schema in SQL way. It also offers the ability to define views on these tables and 
keep a small part that is particularly interesting. It is possible to use our tool to answer the 
question like what is the protein associated with the mutated gene responsible for familial 
hypercholesterolemia and related publications. 
7. Conclusion 
The objective of this work was to develop a system for integrating biological data with an 
application on familial hypercholesterolemia disease. Such a system should facilitate access to 
multiple data sources available on the Web, in a transparent and uniform way, giving 
biologists a single virtual source that summarizes all relevant data sources for the application. 
This chapter describes the solution adopted to achieve such a system, where the main 
elements have been identified, and a computer deployment scenario developed. Among 
different existing integration approaches, we adopted the mediator approach to integrate 
data sources. In this approach the most important step is the construction of the global 
schema as the mediator has to process queries at runtime in order to integrate data sources. 
We first studied the biologists’ needs by exploring different scenarios and we identified with 
their help various data sources involved. 
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A study of these sources was necessary in order to build our global schema. From the diagram 
established, we formulated our SQL query as we built various adapters associated with 
different sources and at the end we have submitted this request to the mediator for treatment. 
As prospects, we have to implement and test this solution and combine the final result of the 
mediator and that of the tool CHARMM before presenting to the user. 
We are currently expanding the platform by integrating other proteins involved in 
cardiovascular diseases which are the main cause of mortality in the world. In particular, we 
are investigating a protein called paraoxonase-1 (PON1) which plays an important role in 
the cardiovascular diseases prevention. 
PON1 is an HDL associated enzyme synthesized in the liver and distributed in the blood. It 
catalyzes the hydrolysis of modified lipids in both HDL (known as good cholesterol) and 
LDL (known as bad cholesterol) particles and protects them from oxidative modifications, 
and subsequently reducing the risk of atherosclerosis. 
Further bioinformatics analysis including molecular simulations are performed on the 
PON1 enzyme to better understand the structure activity relationship and also to explore 
the mutated proteins (genetic polymorphism associated with heart disease) responsible for 
the weak activity revealed trough the clinical study in both diabetic and coronary patients 
from Morocco. 
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